DRUG · Mapped RxNorm record
montelukast
Normalized identity: montelukastView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Montelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)
NCT00756418
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
Theophylline
Normalized identity: theophyllineView linked drug · Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedMontelukast Post-marketing Comparative Study With Theophyline Added to Inhaled Corticosteroid (0476-396)
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Asthmaverified · MONDO: asthma
Interventions
montelukastDRUG · verified · RxNorm: montelukast
TheophyllineDRUG · verified · RxNorm: theophylline
Sponsors & collaborators
Organon and Colead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00756418 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.